Clinical Trial Update: A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1b clinical trial evaluating the safety and pharmacokinetics of MP-376 in patients with chronic obstructive pulmonar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• MP-376

Snippet

Sponsor: Amgen | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED